Asparaginase Market Forecast to 2028

Report Code : TIPRE00008224 | Region : Global | Industry : Pharmaceuticals | Published Date : 19/Aug/2022
Asparaginase Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Escherichia coli, Erwinia chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), End-Use Industry (Healthcare and Food Manufacturing), and Geography

The global asparaginase market is expected to grow from US$ 564.01 million in 2021 to US$ 1,575.62 million by 2028. It is expected to grow with a CAGR of 16.1% from 2022 to 2028.

The rising incidence of leukemia and the significant growth in the pharmaceutical and food industry are the major factors boosting the market.

Asparaginase is a naturally occurring substance that is present in mammals, birds, yeast, plants, and different types of bacteria but Enterobacteriaceae family microorganisms are one of the primary sources of L-asparaginase production. Additionally, there is various research going on for the expansion of its application area in different industries, such as nanomedicine, biomedical engineering, and many more, which is contributing to the market growth. Furthermore, increasing allergic reactions from E. coli, derived L-asparaginase has increased the use of E. chrysanthemi derived L-Asparaginase. Furthermore, the rising demand for better stability in the pharmaceutical industry to ensure efficient storage and transportation of drugs has further increased the R&D activities in the industry. There has been a rising inclination toward lyophilized drugs due to various advantages associated with lyophilized drugs. Thus, all the factors mentioned above are expected to drive the asparaginase market growth in the near future.

Moreover, the increase in population worldwide has further contributed to the growth of the pharmaceutical and food industries. The rising population is fueling the demand for food products and pharmaceuticals. As per the world bank data, the total population was estimated to be 7.84 billion globally in 2021, growing at the rate of 1.05% per year. Thus, an increasing population is contributing to the expansion in the food and pharmaceutical industries, driving the global asparaginase market.

Global Asparaginase Market: Key Insights – Impact of COVID-19 Pandemic

The COVID-19 pandemic offered lucrative opportunities to players operating in the global asparaginase market. The US emerged as one of the most affected countries in North America due to the COVID-19 pandemic. The infection severely affected the country's geriatric population, leading to various health complications among them, followed by the death of a large population.

During COVID-19 has Spain, Italy, UK, France, and Germany were the worst affected European countries. According to Spanish Ministry of Health’s report, 2020, about 1,773,000 cases and 48,000 deaths of COVID-19 were reported in Spain. About 20% of cases were registered in the Community of Madrid, accounting for 11,000 deaths and makes it severely affected areas in Europe. Cancer patients are at high risk of contracting COVID-19 and severe complications. Due to sudden lockdown and movement restriction, only emergency procedures were allowed. Asia Pacific was the first region to face an outbreak, the region has quickly changed how they manage trials, and most are able to deliver the clinical trial services their clients need. Biotech companies are currently initiating more clinical trials in the region. For Instance: since the initial outbreak, the situation in Asia Pacific has improved. As of May 2020, 97% of the sites re-opened for patient visits and 83% of the sites are open for on-site CRA visits. While in MEA and SCAM region COVID-19 pandemic had slight negative impact on the asparaginase market growth.

Type Insights

Based on the type, the global asparaginase market is segmented into Escherichia coli (E. coli), Erwina Chrysanthemi, Pegylated, and others. The E. coli segment held the largest market share in 2021. It is anticipated to register the highest CAGR during the forecast period. The increasing demand for E. coli asparaginase in the cancer treatment and food processing industry promotes the growth of the global asparaginase market. Asparaginase-derived E. coli is used for the treatment of acute lymphoblastic leukemias. Asparaginase E. coli is an enzyme that catalyzes L-asparagine into L-aspartic acid and ammonia. It helps in the production of oxaloacetate needed for cellular metabolism. Asparaginase from E. coli has an antitumor property that is used for the treatment of leukemias.

Application Insights

Based on application, the global asparaginase market is bifurcated into therapeutic, food processing, and others. The therapeutic segment held a larger market share in 2021. Furthermore, the same segment is expected to record a faster CAGR from 2022 to 2028. The increasing use of asparaginase enzyme in treating lymphoproliferative disorders and lymphomas is expected to drive the growth of this segment during the forecasted period. The asparaginase enzyme is also used as an antimicrobial agent to treat infectious and autoimmune diseases, among others. It is administrated by injection into a vein, muscle, or under the skin.

The demand for asparaginase enzyme is growing in the food processing industry as it reduces the acrylamide formation in the food under specific cooking conditions. Continuous innovations and increased demand for processed food are driving the growth of the global asparaginase market. According to the European Food Safety Authority (EFSA 2015), use of L-asparaginase presents a high potential to reduce the acrylamide content in thermally treated food without compromising their sensorial or nutritional aspects.

End-use Industry Insights

Based on end-use industry, the global asparaginase market is segmented into healthcare and food manufacturing. In 2021, the healthcare segment held the largest share in the market. Furthermore, the same segment is expected to register the highest CAGR from 2022 to 2028. The growth of the healthcare segment is attributed to factors such as growing acute lymphocytic leukemia, lymphoblastic lymphoma, and growing research activities.

The rapidly growing healthcare industry is expected to increase the demand for asparaginase during the forecast period. Due to the increasing demand for asparaginase, there is a rising investment by the market players in R&D and the production of asparaginase. For instance, In 2019, researchers at the University of Illinois, Chicago, secured about US$ 1 million in funding for developing a less toxic version of chemotherapy using asparaginase to treat acute lymphoblastic leukemia. Thus, the rise in research activities is anticipated to boost the growth of the global asparaginase market during the forecast period.

The List of Companies - Asparaginase Market

1. Servier Pharmaceuticals LLC

2. Jazz Pharmaceuticals plc

3. BioVendor R&D

4. Creative Enzymes

5. medac GmbH

6. Changzhou Qianhong Bio-pharma Co Ltd

7. United Biotech

8. Porton Biopharma

9. Taj Pharmaceuticals Limited

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Asparaginase Market – By Type

1.3.2 Global Asparaginase Market – By Application

1.3.3 Global Asparaginase Market – By End-Use Industry

1.3.4 Global Asparaginase Market – By Geography

2. Asparaginase Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asparaginase Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Experts Opinion

5. Asparaginase Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Leukemia and Increasing Usage Application

5.1.2 Significant Growth of Pharmaceutical and Food Industry

5.2 Market Restraints

5.2.1 Side Effects Associated With Use of Asparaginase

5.3 Market Opportunities

5.3.1 New Product Launches and Approvals

5.4 Future Trends

5.4.1 Increase in R&D Activities and Investment by Market Players

5.5 Impact Analysis

6. Asparaginase Market– Global Analysis

6.1 Global Asparaginase Market Revenue Forecasts and Analysis

6.1.1 Overview

6.1.2 Global Asparaginase Market, By Geography - Forecasts and Analysis

6.1.3 Global Asparaginase Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Global Asparaginase Market – Market Share Analysis, By Company

6.2.2 Market Positioning of Key Players

6.2.3 Comparative Company Analysis

6.3 Growth Strategy Analysis

6.3.1 Performance of Key Players

6.3.2 Servier Pharmaceuticals LLC

6.3.3 Jazz Pharmaceutical

6.3.4 Porton Biopharma

6.4 Currency with respect to Supplier Company’s Operations

6.5 Profit Margin (Net/Gross Profit) (2021) (Percentage), By Supplier

6.6 Type of Asparaginase Production, By Supplier

7. Asparaginase Market Analysis And Forecasts To 2028 - Type

7.1 Overview

7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)

7.2.1 Escherichia Coli

7.2.1.1 Overview

7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

7.2.2 Erwinia Chrysanthemi

7.2.2.1 Overview

7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

7.2.3 Pegylated

7.2.3.1 Overview

7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)

7.2.4 Others

7.2.4.1 Overview

7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Asparaginase Market Analysis And Forecasts To 2028 - Application

8.1 Overview

8.2 By Application: Market Revenue and Forecast Analysis (US$ Million)

8.2.1 Therapeutic

8.2.1.1 Overview

8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)

8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4 Lymphoblastic Lymphoma (LBL)

8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.5 Others

8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)

8.2.2 Food Processing

8.2.2.1 Overview

8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)

8.2.3 Others

8.2.3.1 Overview

8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)

9. Asparaginase Market Analysis And Forecasts To 2028 – End-use Industry

9.1 By End-Use: Market Revenue and Forecast Analysis (US$ Million)

9.1.1 Healthcare

9.1.1.1 Overview

9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)

9.1.2 Food Manufacturing

9.1.2.1 Overview

9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

10. Global Asparaginase Market – Geographic Analysis

10.1 North America: Asparaginase Market

10.1.1 Overview

10.1.2 North America: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3 North America: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4 North America: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.4.1 North America: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.5 North America: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.6 North America: Asparaginase Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.3 US: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.4 US: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.6.1.4.1 US: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.6.1.5 US: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.6.2 Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.3 Canada: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.4 Canada: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.6.2.4.1 Canada: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.6.2.5 Canada: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.6.3 Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.3 Mexico: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.4 Mexico: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.6.3.4.1 Mexico: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.6.3.5 Mexico: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.2 Europe: Asparaginase Market

10.2.1.1 Overview

10.2.2 Europe: Asparaginase Market - Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.4 Europe: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.5 Europe Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

10.2.6 Europe: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.2.7 Europe: Asparaginase Market, by Country, 2022 & 2028 (%)

10.2.7.1 Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.1.1 Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.1.2 Germany: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.7.1.3 Germany: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.7.1.3.1 Germany Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

10.2.7.1.4 Germany: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.2.7.2 UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.2.1 UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.2.2 UK: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.7.2.3 UK: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.7.2.3.1 UK Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

10.2.7.2.4 UK: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.2.7.3 France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.3.1 France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.3.2 France: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.7.3.3 France: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.7.3.3.1 France Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

10.2.7.3.4 France: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.2.7.4 Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.4.1 Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.4.2 Italy: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.7.4.3 Italy: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.7.4.3.1 Italy: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.2.7.4.4 Italy: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.2.7.5 Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.5.1 Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.5.2 Spain: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.7.5.3 Spain: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.7.5.3.1 Spain: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.2.7.5.4 Spain: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.2.7.6 Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.6.1 Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.2.7.6.2 Rest of Europe: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.2.7.6.3 Rest of Europe: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.2.7.6.3.1 Rest of Europe: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.2.7.6.4 Rest of Europe: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million)

10.3 Asia Pacific: Asparaginase Market

10.3.1 Overview

10.3.2 Asia Pacific: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.4 Asia Pacific: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.4.1 Asia Pacific: Asparaginase Market, by Therapeutic Application, 2019–2028

10.3.5 Asia Pacific: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.3.6 Asia Pacific: Asparaginase Market, by Country, 2022 & 2028 (%)

10.3.6.1 China Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.3 China: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.6.1.4 China: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.6.1.4.1 China Asparaginase Market, by Therapeutic Application – 2020 - 2028 (US$ Million)

10.3.6.1.5 China: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.3.6.2 Japan Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.3 Japan: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.6.2.4 Japan: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.6.2.4.1 Japan: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.3.6.2.5 Japan: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.3.6.3 India Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.3 India: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.6.3.4 India: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.6.3.4.1 India: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.3.6.3.5 India: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.3.6.4 Australia Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 Australia: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.3 Australia: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.6.4.4 Australia: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.6.4.4.1 Australia: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.3.6.4.5 Australia: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.3.6.5 South Korea Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 South Korea: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.3 South Korea: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.6.5.4 South Korea: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.6.5.4.1 South Korea: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.3.6.5.5 South Korea: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.3.6.6 Rest of Asia Pacific Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Asparaginase Market, by Type, 2019–2028 (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Asparaginase Market, by Application, 2019–2028 (US$ Million)

10.3.6.6.4.1 Rest of Asia Pacific: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Asparaginase Market, by End-User, 2019–2028 (US$ Million)

10.4 South & Central America Asparaginase Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 South & Central America: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.3 South & Central America: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.4.4 South & Central America: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.4.4.1 South & Central America: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.4.5 South & Central America: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.4.6 South & Central America: Asparaginase Market, by Country, 2021 & 2028 (%)

10.4.6.1 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.1.1 Overview

10.4.6.1.2 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.1.3 Brazil: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.1.4 Brazil: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.4.6.1.4.1 Brazil: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.4.6.1.5 Brazil: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.4.6.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.2.1 Overview

10.4.6.2.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.2.3 Argentina: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.2.4 Argentina: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.4.6.2.4.1 Argentina: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.4.6.2.5 Argentina: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.4.6.3 Rest of South & Central America: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.3.1 Overview

10.4.6.3.2 Rest of South & Central America: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.3.3 Rest of South & Central America: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.3.4 Rest of South & Central America: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.4.6.3.4.1 Rest of South & Central America: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.4.6.3.5 Rest of South & Central America: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.5 Middle East & Africa Asparaginase Market Revenue and Forecasts To 2028

10.5.1 Overview

10.5.2 Middle East & Africa Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.3 Middle East & Africa: Asparaginase Market By Type, 2020 - 2028 (US$ Million)

10.5.4 Middle East & Africa: Asparaginase Market, by Application, 2020–2028 (US$ Million)

10.5.4.1 Middle East & Africa: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.5.5 Middle East & Africa: Asparaginase Market, by End-Use – 2020 - 2028 (US$ Million)

10.5.6 Middle East & Africa Asparaginase Market Revenue and Forecasts to 2028, By Country (%)

10.5.6.1 Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.1.1 Overview

10.5.6.1.2 Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.1.3 Saudi Arabia: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.1.4 Saudi Arabia: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.1.4.1 Saudi Arabia: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.5.6.1.5 Saudi Arabia: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

10.5.6.2 South Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.2.1 Overview

10.5.6.2.2 South Africa Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.2.3 South Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.2.4 South Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.2.4.1 South Africa: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.5.6.2.5 South Africa: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

10.5.6.3 UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.3.1 Overview

10.5.6.3.2 UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.3.3 UAE: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.3.4 UAE: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.3.4.1 UAE: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.5.6.3.5 UAE: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

10.5.6.4 Rest of Middle East and Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.4.1 Overview

10.5.6.4.2 Rest of Middle East and Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.4.3 Rest of Middle East & Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.4.4 Rest of Middle East & Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.5.6.4.4.1 Rest of Middle East & Africa: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.5.6.4.5 Rest of Middle East and Africa: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Global Asparaginase Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Asparaginase Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Asparaginase market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Servier Pharmaceuticals LLC

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 BIOVENDOR, LLC

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 CREATIVE ENZYMES

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Taj Pharmaceuticals Limited

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Jazz Pharmaceuticals, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Changzhou Qianhong Biopharma Co Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Porton Biopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 United Biotech (P) Limited

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. North America: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3. North America: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4. North America: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. US: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. US: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. US: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. US: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Canada: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. Canada: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. Canada: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. Canada: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Mexico: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14. Mexico: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 15. Mexico: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 16. Mexico: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 17. Europe Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Europe Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 19. Europe Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 20. Europe Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 21. Germany Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Germany Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 23. Germany Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. Germany Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 25. UK Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 26. UK Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 27. UK Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 28. UK Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 29. France Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. France Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 31. France Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 32. France Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 33. Italy Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 34. Italy Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 35. Italy Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

Table 36. Italy Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 37. Spain Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 38. Spain Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 39. Spain Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

Table 40. Spain Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Europe Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 42. Rest of Europe Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 43. Rest of Europe Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

Table 44. Rest of Europe Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million)

Table 45. Asia Pacific Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 46. Asia Pacific: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 47. Asia Pacific Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million)

Table 48. Asia Pacific Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (USD Million)

Table 49. China Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 50. China Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 51. China Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 52. China Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 53. Japan Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 54. Japan Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 55. Japan Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 56. Japan Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 57. India Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 58. India Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 59. India Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 60. India Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 61. Incidence, Mortality and Prevalence by cancer site, Australia, 2018

Table 62. Australia Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 63. Australia Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 64. Australia Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 65. Australia Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 66. South Korea Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 67. South Korea Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 68. South Korea Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 69. South Korea Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 70. Rest of Asia Pacific Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 71. Rest of Asia Pacific Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 72. Rest of Asia Pacific Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million)

Table 73. Rest of Asia Pacific Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 74. South & Central America: Asparaginase Market, by Type– Revenue and Forecast to 2028 (US$ ‘Million)

Table 75. South & Central America: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 76. South & Central America: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 77. South & Central America: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 78. Brazil: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 79. Brazil: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 80. Brazil: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 81. Brazil: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 82. Argentina: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 83. Argentina: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 84. Argentina: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 85. Argentina: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 86. Rest of South & Central America: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 87. Rest of South & Central America: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 88. Rest of South & Central America: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 89. Rest of South & Central America: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 ( US$ ‘Million)

Table 90. Middle East & Africa: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 91. Middle East & Africa: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 92. Middle East & Africa: Asparaginase Market, By Therapeutic Application - Revenue and Forecasts to 2028 (US$ Million)

Table 93. Middle East & Africa: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 94. Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 95. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 96. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 97. Saudi Arabia: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 98. South Africa Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 99. South Africa: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 100. South Africa: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 101. South Africa: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 102. UAE: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 103. UAE: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 104. UAE: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 105. UAE: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 106. Rest of Middle East & Africa: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 107. Rest of Middle East & Africa: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 108. Rest of Middle East & Africa: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 109. Rest of Middle East and Africa: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 110. Recent Inorganic Growth Strategies in the Asparaginase market

Table 111. Recent Organic Growth Strategies in the Asparaginase market

Table 112. Glossary of Terms, Asparaginase Market

The List of Companies - Asparaginase Market

1. Servier Pharmaceuticals LLC

2. Jazz Pharmaceuticals plc

3. BioVendor R&D

4. Creative Enzymes

5. medac GmbH

6. Changzhou Qianhong Bio-pharma Co Ltd

7. United Biotech

8. Porton Biopharma

9. Taj Pharmaceuticals Limited

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the asparaginase market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the global asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth global market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Asparaginase Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry